Literature DB >> 7013858

Functions of granulocytes after allogeneic bone marrow transplantation.

P J van den Broek, J W van der Meer, P C Leijh, F Zwaan, M van den Barselaar, R van Furth.   

Abstract

The phagocytosis and intracellular killing by granulocytes as well as the opsonizing capacity of the serum were studied in 13 patients who had undergone allogeneic bone marrow transplantation. Phagocytosis was normal in all patients. A moderately impaired opsonic activity of the serum was found in two patients, who were investigated within 30 days after the transplantation. The intracellular killing was less than control values in two patients. In one patient this was probably due to the existence of a split chimerism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013858     DOI: 10.1007/bf00996755

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  2 in total

1.  Neutrophil function in bone marrow transplant recipients.

Authors:  M C Territo; R P Gale; M J Cline
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

2.  Partial antibiotic decontamination.

Authors:  H F Guiot; R Furth
Journal:  Br Med J       Date:  1977-03-26
  2 in total
  3 in total

1.  Reconstitution and functional analyses of neutrophils and distinct subsets of monocytes after allogeneic stem cell transplantation.

Authors:  Maraike Rommeley; Baerbel Spies-Weisshart; Kristina Schilling; Andreas Hochhaus; Herbert G Sayer; Sebastian Scholl
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-29       Impact factor: 4.553

2.  Distinct reconstitution of neutrophil functions after allogeneic peripheral blood stem cell transplantation.

Authors:  S Scholl; M Hanke; K Höffken; H G Sayer
Journal:  J Cancer Res Clin Oncol       Date:  2007-01-24       Impact factor: 4.322

Review 3.  Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation.

Authors:  Cristina Tecchio; Marco Antonio Cassatella
Journal:  Cell Mol Immunol       Date:  2020-11-17       Impact factor: 11.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.